tiprankstipranks
Trending News
More News >

Cyclopharm Director Increases Shareholding

Story Highlights
Cyclopharm Director Increases Shareholding

Confident Investing Starts Here:

Cyclopharm Limited ( (AU:CYC) ) just unveiled an update.

Cyclopharm Limited has announced a change in the director’s interest, with Director David James Heaney acquiring 8,874 ordinary shares through an on-market trade, increasing his total holdings to 310,000 shares. This change in shareholding reflects a continued confidence in the company’s growth prospects and may influence investor perception positively, potentially impacting the company’s market positioning and stakeholder interests.

More about Cyclopharm Limited

Cyclopharm Limited operates in the healthcare industry, primarily focusing on the development and distribution of medical equipment and pharmaceuticals. The company is known for its specialized products that cater to the needs of the medical imaging sector.

YTD Price Performance: 20.25%

Average Trading Volume: 110,041

Technical Sentiment Consensus Rating: Strong Sell

Current Market Cap: A$211.2M

See more data about CYC stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App